PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

The company is focused on developing treatments for cancer and autoimmune conditions. Credit: arrowsmith2/Shutterstock. China’s National Medical Products ...

MET is a tyrosine kinase receptor that has an essential role in normal cell development ... Datroway is comprised of a humanised anti-TROP2 IgG1 monoclonal antibody, developed in collaboration with ...

Such treatment forms innovatively designed prove excellent for selectively targeting HER2 receptors ... innovations include antibody-drug conjugates such as Enhertu (trastuzumab deruxtecan), and ...

Overexpression of the RON receptor tyrosine kinase exists in various cancers and contributes ... were formulated followed by postinsertion of monoclonal antibodies Zt/g4, Zt/c1, or their Fab fragments ...

One such family of receptor tyrosine kinases is epidermal growth factor receptor (EGFR) tyro- sine kinase. These receptors are overexpressed ... knowledge of such EGFR inhibitors as monoclonal ...

Discoidin domain receptors (DDRs ... Figure 1. DDR1 kinase activity is necessary for SMC migration to collagen but not for SMC attachment to collagen. A, Western blot probed with an anti-DDR1 antibody ...